C-Reactive Protein Testing Market Size, Share, Growth Analysis, By Assay Type (Immunoturbidimetric Assay, Elisa), By Detection Range (HS-CRP, Conventional CRP), By Disease Area, By End-Use, By Region - Industry Forecast 2024-2031

Global C-Reactive Protein Testing Market size was valued at USD 4.5 billion in 2022 and is poised to grow from USD 4.6 billion in 2023 to USD 5.52 billion by 2031, growing at a CAGR of 2.3% during the forecast period (2024-2031).

The global market for C-reactive protein testing is poised for significant growth, driven by advancements in nanotechnology that enhance specificity, sensitivity, and rapid on-site disease diagnosis. New point-of-care assays for CRP testing are emerging, responding to the increasing demand for swift diagnostic tools. Research from Mohammed VI University highlights CRP's potential in assessing SARS-CoV-2 severity, further cementing its relevance. Additionally, the rising prevalence of inflammatory disorders, diabetes, and cancers, alongside a growing incidence of endometriosis and increased funding in diagnostics, is expected to fuel market expansion. Notably, the CDC reported that over 20.1 million adults in the U.S. suffer from coronary artery disease, a number anticipated to rise, thereby amplifying market opportunities in this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global C-Reactive Protein Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global C-Reactive Protein Testing Market Segmental Analysis

Global C-Reactive Protein Testing Market is segmented by assay type, detection range, disease area, end-use and region. Based on assay type, the market is segmented into immunoturbidimetric assay, ELISA, chemiluminescence immunoassay and others. Based on detection range, the market is segmented into HS-CRP, conventional CRP and cCRP. Based on disease area, the market is segmented into cardiovascular diseases, cancer, rheumatoid arthritis, inflammatory bowel disease, endometriosis, lupus and others. Based on end-use, the market is segmented into clinics, hospitals, laboratories, assisted living healthcare facilities, home and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global C-Reactive Protein Testing Market

The global C-reactive protein testing market is poised for significant growth, primarily fueled by the increasing prevalence of cardiovascular diseases. With over 800,000 fatalities attributed to cardiovascular conditions annually in the United States alone, the demand for effective C-reactive protein testing methods is surging. Additionally, the ongoing research and development aimed at enhancing these testing methodologies will further propel market expansion. The combination of an ageing population and a rising incidence of diabetes mellitus also contributes to this upward trend, indicating a robust market potential in the foreseeable future as healthcare providers seek better diagnostic solutions.

Restraints in the Global C-Reactive Protein Testing Market

The global C-Reactive Protein Testing market is likely to face significant restraints primarily due to low awareness about CRP testing and the limited availability of advanced technologies in lower and medium-sized economies worldwide. This lack of knowledge can lead to underutilization of these important diagnostic tools, hindering market expansion. Furthermore, the high costs associated with CRP testing procedures and the substantial initial investments required to establish appropriate setups could further inhibit growth in the market. Together, these factors pose considerable challenges that may slow down the adoption and proliferation of C-reactive protein testing solutions globally during the forecast period.

Market Trends of the Global C-Reactive Protein Testing Market

The global C-Reactive Protein (CRP) testing market is experiencing significant growth, driven by heightened awareness programs and government initiatives aimed at educating the public on chronic disease prevention and treatment. This surge in awareness has led to the widespread integration of CRP testing in routine clinical practices, particularly in developed regions such as the United States, Germany, France, and Japan. As healthcare providers increasingly prioritize CRP tests for assessing inflammation and guiding treatment decisions, the market is poised for robust expansion in the coming years, reflecting a shift towards proactive health management and early disease detection.